On Thursday, the public had the first chance to air their grievances about the FDA’s controversial Commissioner’s National ...

The US biotech’s technology integrates multiple protein modalities to simultaneously target a variety of disease mechanisms.

During the quarter ended March 31, 2026, Baron Health Care Fund® (the Fund) declined 6.97% (Institutional Shares), compared ...

Barry Sharpless and his team first popularised the concept of ‘clicking’ two molecules together back in 2001 – 25 years ago this month. The review paper that launched a new field has now been cited ...

At the Hubbis Independent Wealth Management Forum - Singapore 2026, San Lo, Director, Intermediary Sales at Janus Henderson Investors, set out a case for reassessing China through a more selective, ...

By John Vandermosten, CFA NASDAQ: RNAZ READ THE FULL RNAZ RESEARCH NOTE RNA Oncology Ribonucleic acid (RNA) oncology is a specialized field in the cancer space that focuses on using RNA-based ...

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs can precisely ...

Antibody-drug conjugates (ADCs) have emerged as one of the most impactful therapeutic advances in modern oncology, fundamentally reshaping the treatment landscape across both hematologic malignancies ...

Building useful quantum technologies—from sensors to computers—requires generating highly complex entangled states, in which the properties of particles are deeply intertwined. Producing such states ...

A complex is a part of the psyche that can take over your mind and body. You can’t eliminate it, but you can learn to relate to it differently.

The conjugate space is evolving fast - moving beyond traditional ADCs into new formats like degrader-conjugates, oligonucleotide conjugates, bispecific ADCs, and more. The 4 th Novel Conjugates Summit ...